Cancers with epidemiologic signatures of viral oncogenicity among immunocompromised populations in the United States.

MLA

Haas, Cameron B., et al. “Cancers with Epidemiologic Signatures of Viral Oncogenicity among Immunocompromised Populations in the United States.” JNCI: Journal of the National Cancer Institute, vol. 116, no. 12, Dec. 2024, pp. 1983–91. EBSCOhost, https://doi.org/10.1093/jnci/djae159.

APA

Haas, C. B., Shiels, M. S., Pfeiffer, R. M., D’Arcy, M., Luo, Q., Yu, K., Austin, A. A., Cohen, C., Miller, P., Morawski, B. M., Pawlish, K., Robinson, W. T., & Engels, E. A. (2024). Cancers with epidemiologic signatures of viral oncogenicity among immunocompromised populations in the United States. JNCI: Journal of the National Cancer Institute, 116(12), 1983–1991. https://doi.org/10.1093/jnci/djae159

Chicago

Haas, Cameron B, Meredith S Shiels, Ruth M Pfeiffer, Monica D’Arcy, Qianlai Luo, Kelly Yu, April A Austin, et al. 2024. “Cancers with Epidemiologic Signatures of Viral Oncogenicity among Immunocompromised Populations in the United States.” JNCI: Journal of the National Cancer Institute 116 (12): 1983–91. doi:10.1093/jnci/djae159.